Steven S. Fakharzadeh
Dermatology
3400 Civic Center Boulevard
South Pavilion, 1st Floor
Philadelphia, PA 19104
South Pavilion, 1st Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Characteristics of Real-World Patients with Psoriasis Receiving Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Journal: Journal of psoriasis and psoriatic arthritis
Published: May 11, 2026
Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling.
Journal: Frontiers in immunology
Published: November 22, 2024
Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy.
Journal: JID innovations : skin science from molecules to population health
Published: February 02, 2024
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.
Journal: Frontiers in immunology
Published: October 31, 2023
The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases.
Journal: Advances in therapy
Published: June 22, 2023
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
Journal: The Journal of investigative dermatology
Published: March 14, 2023
Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 20, 2023
Determinants of patient and physician treatment satisfaction in moderate-to-severe psoriasis: a multinational survey of psoriasis patients.
Journal: Dermatology online journal
Published: December 09, 2021
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.
Journal: Journal of the American Academy of Dermatology
Published: April 07, 2021
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.
Journal: Drug safety
Published: March 19, 2021
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis.
Journal: Journal of the American Academy of Dermatology
Published: April 21, 2020
Last Updated: 09/26/2026